Back
PotlatchDeltic 10K Form
Buy
53
PCH
PotlatchDeltic
Last Price:
42.30
Seasonality Move:
4.24%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-03 | 10Q | PCH/PotlatchDeltic Quarterly |
2023-11-03 | 10Q | PCH/PotlatchDeltic Quarterly |
2023-08-04 | 10Q | PCH/PotlatchDeltic Quarterly |
2023-04-28 | 10Q | PCH/PotlatchDeltic Quarterly |
2022-10-28 | 10Q | PCH/PotlatchDeltic Quarterly |
2022-07-29 | 10Q | PCH/PotlatchDeltic Quarterly |
Receive PCH News And Ratings
See the #1 stock for the next 7 days that we like better than PCH
PCH Financial Statistics
Sales & Book Value
Annual Sales: | $1.02B |
---|---|
Cash Flow: | $-6.42M |
Price / Cash Flow: | 539.98 |
Annual Sales: | $26.02 |
Price / Book: | 1.62 |
Profitability
EPS (TTM): | 0.20440 |
---|---|
Net Income (TTM): | $16.54M |
Gross Margin: | $124.5M |
Return on Equity: | 0.77% |
Return on Assets: | 0.48% |
PotlatchDeltic Earnings Forecast
Key PotlatchDeltic Financial Ratios
- The Gross Profit Margin over the past 40 years for PCH is 12.16%.
- The Selling, General & Administrative Expenses for PCH have been equal to 7.39% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 39.00% of Operating Income.
- The Net Earning history of PCH is 6.06% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 19 years.
PotlatchDeltic Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Specialized REITs |
Sector: | Real Estate |
Current Symbol: | PCH |
CUSIP: | 737630 |
Website: | potlatchdeltic.com |
Debt
Debt-to-Equity Ratio: | 0.5 |
---|---|
Current Ratio: | 1.24 |
Quick Ratio: | 0.73 |
Price-to-Earnings
Trailing P/E Ratio: | 54.94 |
---|---|
Forward P/E Ratio: | 55.36 |
PCH Technical Analysis vs Fundamental Analysis
Buy
53
PotlatchDeltic (PCH)
is a Buy
Is PotlatchDeltic a Buy or a Sell?
-
PotlatchDeltic stock is rated a Buy
The current PotlatchDeltic [PCH] share price is $42.30. The Score for PCH is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.